Encompass Health Corporation (EHC)
Are Investors Undervaluing Encompass Health (EHC) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
EHC vs. CHE: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Encompass Health (EHC) and Chemed (CHE). But which of these two stocks presents investors with the better value opportunity right now?
Why Encompass Health (EHC) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Should Value Investors Buy Encompass Health (EHC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
EHC or ASTH: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Encompass Health (EHC) and Astrana Health, Inc. (ASTH). But which of these two stocks presents investors with the better value opportunity right now?
Encompass Health Corporation (EHC) Hits Fresh High: Is There Still Room to Run?
Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Encompass Health (EHC) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Encompass Health Q3 Earnings Beat on Higher Discharges, Stock Up 6.3%
EHC's third-quarter results benefit from improved patient discharges. Higher operating expenses act as a partial offset.
Encompass Health Corporation (EHC) Q3 2024 Earnings Call Transcript
Encompass Health Corporation (NYSE:EHC ) Q3 2024 Earnings Conference Call October 29, 2024 10:00 AM ET Company Participants Mark Miller - Chief Investor Relations Officer Mark Tarr - President and Chief Executive Officer Douglas Coltharp - Executive Vice President and Chief Financial Officer Conference Call Participants Christian Porter - Bank of America Securities Andrew Mok - Barclays Michael Murray - RBC Capital Markets Meghan Holtz - Jefferies Kieran Ryan - Deutsche Bank Scott Fidel - Stephens Jared Haase - William Blair Zach Haggerty - KeyBanc Capital Markets Operator Good morning, everyone, and welcome to Encompass Health's Third Quarter 2024 Earnings Conference Call. At this time, I would like to inform all participants that their lines will be in a listen-only mode.
Compared to Estimates, Encompass Health (EHC) Q3 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Encompass Health (EHC) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Encompass Health (EHC) Tops Q3 Earnings and Revenue Estimates
Encompass Health (EHC) came out with quarterly earnings of $1.03 per share, beating the Zacks Consensus Estimate of $0.94 per share. This compares to earnings of $0.86 per share a year ago.
Are Investors Undervaluing Encompass Health (EHC) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
